You Searched For "Bharat Biotech"

Bharat Biotech, Bilthoven Biologicals partner for Oral Polio Vaccine production
Bharat Biotech, Bilthoven Biologicals partner for Oral Polio Vaccine production

BBIL and BBio wherein BBIL will procure drug substances to produce oral polio vaccines to be supplied within India and globally

By Kaniza Garari  Published on 2 April 2024 10:11 AM GMT


Bharat Biotechs first intra nasal Covid vaccine approved for emergency use
Bharat Biotech's first intra nasal Covid vaccine approved for emergency use

The vaccine can be used by those who are 18 years and above. It can be delivered via drops in the nose. This is the first vaccine that will protect...

By Newsmeter Network  Published on 6 Sep 2022 1:34 PM GMT


Nigeria introduces Bharat Biotechs ROTAVAC® vaccine for immunization in children
Nigeria introduces Bharat Biotech's ROTAVAC® vaccine for immunization in children

Nigeria currently accounts for 14% of all childhood rotavirus deaths globally, making it the country with the second-highest number of rotavirus...

By Newsmeter Network  Published on 24 Aug 2022 10:01 AM GMT


Hyd firm Bharat Biotechs intranasal Covid-19 vaccine completes trials
Hyd firm Bharat Biotech's intranasal Covid-19 vaccine completes trials

The data from phase III human clinical trials are submitted for approval to the National Regulatory Authorities

By Newsmeter Network  Published on 15 Aug 2022 11:11 AM GMT


Vaccine couple Krishna Ella, Suchitra Ella conferred Padma Bhushan
Vaccine couple Krishna Ella, Suchitra Ella conferred Padma Bhushan

Dr. Ella strongly believes that innovative technology in vaccine development is essential to solve public healthcare problems caused by infectious...

By Newsmeter Network  Published on 28 March 2022 2:52 PM GMT


Vaccine Couple: Bharat Biotechs Krishna and Suchitra Ella conferred Padma Bhushan
Vaccine Couple: Bharat Biotech's Krishna and Suchitra Ella conferred Padma Bhushan

Hyderabad: Bharat Biotech Managing Director couples Krishna and Suchitra Ella have been conferred with Padma Bhushan 2022 among others.Dr. Krishna...

By Newsmeter Network  Published on 25 Jan 2022 4:15 PM GMT


Bharat Biotechs `Covaxin has neutralizing potential against Omicron: Study
Bharat Biotech's `Covaxin' has neutralizing potential against Omicron: Study

A new study has revealed that Bharat Biotech’s Covaxin (BBV152) has the neutralizing potential against Variants of Concern including, Alpha, Beta,...

By Newsmeter Network  Published on 13 Jan 2022 2:40 AM GMT


Covaxin booster dose confers long-term protection, claims Bharat Biotech
Covaxin booster dose confers long-term protection, claims Bharat Biotech

Bharat Biotech also mentioned that Covaxin was the first vaccine in India to report sustainability of immune responses six months after the second...

By Newsmeter Network  Published on 8 Jan 2022 2:13 PM GMT


`Covaxin safe for children: Hyderabad-based Bharat Biotech
`Covaxin' safe for children: Hyderabad-based Bharat Biotech

Bharat Biotech International Limited (BBIL), on Thursday said Covaxin has been found to be safe, well-tolerated, and immunogenic in pediatric subjects...

By Newsmeter Network  Published on 31 Dec 2021 4:37 AM GMT


Covaxin gets govt nod for emergency use on 12-18 age group
Covaxin gets govt nod for emergency use on 12-18 age group

Covaxin is formulated uniquely such that the same dosage can be administered to adults and children, Hyderabad vaccine maker said in a statement here...

By Newsmeter Network  Published on 26 Dec 2021 5:21 AM GMT


`Vaccine diplomacy: Hyderabad-based Bharat Biotech to donate 2L `Covaxin doses to Vietnam
`Vaccine diplomacy': Hyderabad-based Bharat Biotech to donate 2L `Covaxin' doses to Vietnam

Hyderabad-based Bharat Biotech will donate two lakh doses of `Covaxin’ to the Republic of Vietnam.

By Newsmeter Network  Published on 17 Dec 2021 3:21 AM GMT


Bharat Biotechs `Covaxin only vaccine to be 65.2% effective against Delta variant: The Lancet
Bharat Biotech's `Covaxin' only vaccine to be 65.2% effective against Delta variant: The Lancet

The safety and efficacy analysis data from Phase III clinical trials of Covaxin has been peer-reviewed and published in The Lancet.

By Newsmeter Network  Published on 12 Nov 2021 2:57 AM GMT


Share it